Clinical characteristics and outcomes of isolated myeloid sarcoma without bone marrow involvement: An experience from a tertiary cancer care center in India
Isolated MS is a rare presentation of AML. It has a better prognosis than MS with concomitant marrow involvement. Systemic chemotherapy is an essential component of treatment, but the optimal timing is debatable, that is, at diagnosis or if it can be safely deferred until relapse.
Authors
- L K Rajeev
- D. Lokanatha
- Smitha Saldanha (ORCID: https://orcid.org/0000-0002-8298-0705)
- Antony G. F. Thottian
- CS Premalatha
- Sreevalli Anantharamu
- A.H. Rudresha
- Pravin Khandare
- M. C. Suresh Babu
- Linu Abraham Jacob
- K. Govind Babu
- G. V. Giri
- Geeta V. Patil Okaly
- K.N. Lokesh
Institutions
- Kidwai Memorial Institute of Oncology (IN)
Publication Details
- Journal
- Indian Journal of Cancer
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4103/ijc.ijc_84_22
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00